Active Hemostatic Agents Market 2028 By Product Type, End User | The Insight Partners

report image

Active Hemostatic Agents Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type (thrombin based hemostats, surgical sealants, combination products); End User (hospitals, ambulatory surgical centers, specialty clinics)

Report Code: TIPRE00011954 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Hemostatic agents are medical devices that are utilized to control bleeding during surgical procedures. Also, advancements in hemostasis technology have led to the development of a wide range of products that have enabled clinicians to provide proper emergency assistance to patients. Hemostatic products include thrombin sealants, fibrin glue, bovine serum/albumin/glutaraldehyde, gelatin matrix, microfibrillar collagen matrix, and oxidized regenerated cellulose. However, active hemostatic agents act physiologically by countering with blood coagulation cascade and lead to faster hemostasis.


The active hemostatic agents market is driving due to an increase in global trauma and accident cases. However, strict but inconsistent regulatory policies across the world are creating apprehensive environment among the market players, thereby restraining market growth of active hemostatic agents market. Moreover, the patient pool with different chronic diseases is also growing rapidly across the world.


The "Active Hemostatic Agents Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of active hemostatic agents market with detailed market segmentation by product type and end user. The active hemostatic agents market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in active hemostatic agents market and offers key trends and opportunities in the market.


The active hemostatic agents market is segmented on the basis of product type and end user. Based on product type, the market is segmented as thrombin-based hemostats, surgical sealants, combination products. On the basis of end user, the market is categorized as hospitals, ambulatory surgical centers, and specialty clinics.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the active hemostatic agents market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The active hemostatic agents market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting active hemostatic agents market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the active hemostatic agents market in these regions.

Get more information on this report :


The report covers key developments in the active hemostatic agents market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from active hemostatic agents market are anticipated to have lucrative growth opportunities in the future with the rising demand for active hemostatic agents in the global market. Below mentioned is the list of few companies engaged in the active hemostatic agents market.

The report also includes the profiles of key players in active hemostatic agents market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Baxter International Inc.
  •   CryoLife, Inc.
  •   Ethicon Inc. (part of Johnson & Johnson Company)
  •   Integra Life Sciences Corporation
  •   Medtronic Plc.
  •   Pfizer Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Baxter International Inc.
2. CryoLife, Inc.
3. Ethicon Inc. (part of Johnson & Johnson Company)
4. Integra Life Sciences Corporation
5. Medtronic Plc.
6. Pfizer Inc.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount